Source: Health Canada shortage reports · Updated Sep 17, 2026
Raloxifene has no current shortage reported in Canada. It has been in shortage before; the history is below.
A selective estrogen receptor modulator used to prevent and treat osteoporosis in postmenopausal women.
Products affected
0 / 6
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
JAMP RALOXIFENE
60MG · TABLET · JAMP PHARMA CORPORATION
DIN 02540681 · ended Sep 15, 2026 · Disruption of the manufacture of the drug.
Discontinued
EVISTA
60MG · TABLET · ELI LILLY CANADA INC
DIN 02239028
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended May 20, 2025 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-RALOXIFENE
60MG · TABLET · APOTEX INC
DIN 02279215 · ended Apr 20, 2023 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Apr 20, 2022 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended May 5, 2021 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Dec 2, 2020 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Nov 25, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-RALOXIFENE
60MG · TABLET · APOTEX INC
DIN 02279215 · ended Oct 30, 2020 · Disruption of the manufacture of the drug.
Resolved
RALOXIFENE
60MG · TABLET · PRO DOC LIMITEE
DIN 02415852 · ended May 30, 2018 · Discontinued as of April 26, 2018
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Raloxifene. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Raloxifene is classified under “OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM” (ATC G03XC).
Recent changes
Sep 17, 2026
Shortage resolved
Jul 29, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 21, 2026
Common questions
What is Raloxifene used for?
A selective estrogen receptor modulator used to prevent and treat osteoporosis in postmenopausal women.
When will Raloxifene be back in stock in Canada?
Raloxifene has no active shortage; supply is normal per Health Canada reports.
Why is Raloxifene in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.